A NECTAR AGAINST
ALZHEIMER

THE “NEUTRON
CAPTURE-ENHANCED
TREATMENT OF
NEUROTOXIC AMYLOID
AGGREGATES” PROJECT.

Discover objectives, background and work packages of NECTAR project: our vision to fight Alzheimer’s Disease (AD).

Consortium partners

18-22 SEPTEMBER
PIANOFORTE
TRAINING COURSE

PRO_TREAT – PROtecting while TREATing: from the basic principles of the biological effects of ionizing radiations up to their use in neurodegenerative diseases

Discover the program

AN ALTERNATIVE AND REVOLUTIONARY
STRATEGY TO ADDRESS ALZHEIMER DISEASE

Publications, news and congresses

Publications

E.Azzi, D.Alberti, S.Parisotto, A.Oppedisano, N.Protti, S.Altieri, S.Geninatti-Crich, A.Deagostino

“Design, synthesis and preliminary in-vitro studies of novel boronated mono carbonyl analogues of Curcumin (BMAC) for antitumor and beta-amyloid disaggregation activity”, Bioorg Chem 2019 93:103324

News

June 10-16 2023

Travel Grant awarded to Valeria Pascali of UNIPV team to participate in PTCOG61 in Madrid

May 26 2023

NECTAR second Reporting Meeting (on-line).

May 10-11 2023

Third in presence NECTAR meeting @ Pavia University

March 31 2023

NECTAR second year ended.

March 18 2023

Open Day @ IRFMN involving the NECTAR members from IRFMN

ALZHEIMER DISEASE IS THE
MOST COMMON CAUSE OF DEMENTIA

Contact

nicoletta.protti@unipv.it
Privacy Policy
Cookie Policy

About FET-OPEN program (now evolved in EIC Pathfinder Open)

FET (Future and Emerging Technologies) Open European program provides support for the earliest stage of new cutting-edge researches in any field of science and technologies. It is now evolved in the EIC Pathfinder Open, that continues the mission embracing high-risk, high- gain projects and interdisciplinary collaborations that drive technological breakthroughs. The program aims to go beyond existing knowledge and encourages visionary thinking to pave the way for innovations, radical new ideas and novel technologies, with potential to create new markets and opportunities.

This project has received funding from the European Union's Horizon 2020 research and innovation programme under Grant Agreement No. 964934

© 2023 Nectar Consortium. All rights reserved.